Cathie Wood’s ARK ETFs have made significant moves in the stock market on Friday, April 4th, 2025, with notable transactions across various sectors. The investment management firm’s daily trade report reveals a mix of both buying and selling activities that may signal strategic shifts in their portfolio.
Leading the purchases, ARK bought a substantial number of shares in COINBASE GLOBAL INC (NASDAQ:), totaling 83,157 across three of its funds, with a combined dollar value of approximately $14.2 million. This move comes amidst a broader trend of ARK increasing its stake in the cryptocurrency exchange platform, suggesting a bullish outlook on the digital currency sector.
AMAZON.COM INC (NASDAQ:) also saw a significant boost from ARK, with a total of 54,120 shares acquired across four different ETFs, amounting to nearly $9.7 million. This buy reflects ARK’s continued confidence in the e-commerce giant, which has been a recurring theme in the firm’s investment strategy.
In the biotech sphere, ARK further invested in BEAM THERAPEUTICS INC (NASDAQ:) by purchasing 142,713 shares through its ARKK ETF, reflecting a value of about $2.3 million. Similarly, 69,011 shares of CRISPR THERAPEUTICS AG (NASDAQ:) were bought, totaling roughly $2.25 million, indicating ARK’s ongoing interest in gene-editing technology companies.
On the selling side, ARK reduced its holdings in several companies. Most notably, it sold a significant portion of UIPATH INC (NYSE:) shares, with 1,354,254 sold across four ETFs, valued at nearly $13.9 million. This divestment continues a selling trend from previous days, hinting at a potential strategic shift away from the robotic process automation company.
ROBLOX CORP (NYSE:) also experienced a considerable sell-off, with 283,765 shares worth approximately $16.5 million being sold from two ETFs. This follows a similar large-scale sale of Roblox stock by ARK last week, possibly indicating a diminishing conviction in the online gaming platform’s near-term prospects.
Additionally, smaller sales were made in MERCADOLIBRE INC (NASDAQ:) and REPARE THERAPEUTICS INC (NASDAQ:), with 1,050 and 32,613 shares sold, respectively, for a combined value of around $2 million.
Investors and market analysts closely watch ARK’s daily trades, as Cathie Wood’s ETFs have garnered significant attention for their focus on disruptive innovation. The latest transactions provide insight into the firm’s evolving investment strategy and may influence market sentiment towards the stocks involved.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
